Cargando…
Fatalities associated with gabapentinoids in England (2004–2020)
The gabapentinoids were reclassified as Schedule II medications and Class C drugs in the UK in 2019 due to their potential misuse. In this study we examined deaths following gabapentinoid use in England reported to the National Programme on Substance Abuse Deaths. A total of 3051 deaths were reporte...
Autores principales: | Kalk, Nicola J., Chiu, Ching‐Ting, Sadoughi, Rasa, Baho, Heli, Williams, Bryn D., Taylor, David, Copeland, Caroline S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543893/ https://www.ncbi.nlm.nih.gov/pubmed/35435281 http://dx.doi.org/10.1111/bcp.15352 |
Ejemplares similares
-
Opioid and gabapentinoid prescriptions in England from 2015 to 2020
por: Xia, Yixue, et al.
Publicado: (2022) -
Trends in deaths following drug use in England before, during, and after the COVID-19 lockdowns
por: Sekeris, Athanasios, et al.
Publicado: (2023) -
Fatal Babesiosis in Man, Finland, 2004
por: Haapasalo, Karita, et al.
Publicado: (2010) -
Current Evidence on Abuse and Misuse of Gabapentinoids
por: Hägg, Staffan, et al.
Publicado: (2020) -
Trends in the epidemiology of larynx and lung cancer in south-east England, 1985–2004
por: Coupland, V H, et al.
Publicado: (2009)